Neuroprotection Market 2025 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Neuroprotection Market to 2025 - Global Analysis and Forecasts By Product (Free Radical Trapping Agents (Antioxidants), Apoptosis Inhibitors, Anti-inflammatory Agents, Glutamate Antagonists (Anti-Excitotoxic Agents), Metal Ion Chelators and Others), Application (Treatment and Prevention) and Geography

Report Code: TIPMD00002291 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
Neuroprotection is involvement capable to affect the etiology or the pathogenesis of the neurodegenerative diseases. They delay the onset or the development of neurodegenerative diseases. Neuroprotective products are medications that protect the brain neurons from deterioration and injury. These products are used in the cure of several central nervous system complications such as Alzheimer's disease, Parkinson's disease and traumatic brain injuries among others. Neuroprotective agents in clinical pipelines comprise small-molecule drugs, gene and cell therapies, therapeutic monoclonal antibodies and other agents

The neuroprotection market of is expected to grow with a significant rate in the forecast years, owing to driving factors such as, growing drug development in the pharmaceutical and biotechnology industry along with increasing patient population pool, rising incidences of CNS diseases, increased demand for more target specific drug treatment for neurodegenerative diseases with favorable government regulations. The increasing healthcare infrastructure, increasing economic stability in developing economies, are likely to offer more opportunities in the neuroprotection market.

The “Global Neuroprotection Market Analysis To 2025” is a specialized and in-depth study of the medical device industry with a focus on the global market trend. The report aims to provide an overview of global neuroprotection market with detailed market segmentation by product, application and geography. The global neuroprotection market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading market players and offers key trends and opportunities in the Neuroprotection market.

The global neuroprotection market is segmented on the basis of product and application. Based on product, the neuroprotection market has been segmented into free radical trapping agents (antioxidants), apoptosis inhibitors, anti-inflammatory agents, glutamate antagonists (anti-excitotoxic agents), metal ion chelators and others. The application segment is classified as treatment and prevention.

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global neuroprotection market based on product, application and geography. It also provides market size and forecast till 2025 for overall neuroprotection market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 13 counties globally along with current trend and opportunities prevailing in the region.

North America is expected to contribute to the largest share in the neuroprotection market in the coming years, owing to factors such as, various market players operate in this region. The European region is expected to hold the second largest market for the neuroprotection. Asia Pacific is anticipated to be the fastest growing market as the due to the growing number of the neurological disorders in the countries, effect of pricing pressure due to grown competition amongst important brands, rise of generic products and growing number of regional players who are able to provide products at much lower prices.

The report analyzes factors affecting market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions.

The report also includes the profiles of key neuroprotection market manufacturing companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years. Some of the key players influencing the market are Eli Lilly and Company, Allergan plc, Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company, Novartis AG, F. Hoffmann-La Roche AG, AstraZeneca plc, Biogen Inc., Astrocyte Pharmaceuticals, Inc. and other prominent players.
Table of Contents

1. INTRODUCTION
1.1. SCOPE OF STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE

2. KEY TAKEAWAYS

3. NEUROPROTECTION MARKET LANDSCAPE
3.1. MARKET OVERVIEW
3.2. MARKET SEGMENTATION
3.2.1. Neuroprotection Market – By Product
3.2.2. Neuroprotection Market – By Application
3.2.3. Neuroprotection Market – By Region
3.2.3.1. By Country

4. NEUROPROTECTION MARKET – KEY INDUSTRY DYNAMICS
4.1. KEY MARKET DRIVERS
4.2. KEY MARKET RESTRAINTS
4.3. KEY MARKET OPPORTUNITIES
4.4. IMPACT ANALYSIS

5. NEUROPROTECTION MARKET – GLOBAL ANALYSIS
5.1. GLOBAL NEUROPROTECTION MARKET OVERVIEW
5.2. GLOBAL NEUROPROTECTION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
5.3. PERFORMANCE OF KEY PLAYERS
5.4. EXPERT OPINIONS
?

6. NEUROPROTECTION MARKET REVENUE AND FORECASTS TO 2025 – BY PRODUCT
6.1. OVERVIEW
6.2. PRODUCT MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
6.3. FREE RADICAL TRAPPING AGENTS (ANTIOXIDANTS) MARKET
6.3.1. Overview
6.3.2. Free Radical Trapping Agents (Antioxidants) Market Revenue Forecasts and Analysis (US$ Mn)
6.4. APOPTOSIS INHIBITORS MARKET
6.4.1. Overview
6.4.2. Apoptosis Inhibitors Market Revenue Forecasts and Analysis (US$ Mn)
6.5. GLUTAMATE ANTAGONISTS (ANTI-EXCITOTOXIC AGENTS) MARKET
6.5.1. Overview
6.5.2. Glutamate Antagonists (Anti-Excitotoxic Agents) Market Revenue Forecasts and Analysis (US$ Mn)
6.6. ANTI-INFLAMMATORY AGENTS MARKET
6.6.1. Overview
6.6.2. Anti-inflammatory Agents Market Revenue Forecasts and Analysis (US$ Mn)
6.7. METAL ION CHELATORS MARKET
6.7.1. Overview
6.7.2. Metal Ion Chelators Market Revenue Forecasts and Analysis (US$ Mn)
6.8. OTHERS MARKET
6.8.1. Overview
6.8.2. Others Market Revenue Forecasts and Analysis (US$ Mn)

7. NEUROPROTECTION MARKET REVENUE AND FORECASTS TO 2025 – BY APPLICATION
7.1. OVERVIEW
7.2. APPLICATION MARKET REVENUE AND FORECASTS ANALYSIS (US$ MN)
7.3. TREATMENT MARKET
7.3.1. Overview
7.3.2. Treatment Market Revenue Forecasts and Analysis (US$ Mn)
?
7.4. PREVENTION MARKET
7.4.1. Overview
7.4.2. Prevention Market Revenue Forecasts and Analysis (US$ Mn)

8. NORTH AMERICA NEUROPROTECTION MARKET REVENUE AND FORECASTS TO 2025 – COUNTRY ANALYSIS
8.1. NORTH AMERICA NEUROPROTECTION MARKET OVERVIEW
8.2. NORTH AMERICA NEUROPROTECTION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
8.3. NORTH AMERICA NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY PRODUCT (US$ MN)
8.4. NORTH AMERICA NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY APPLICATION (US$ MN)
8.5. NORTH AMERICA NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY COUNTRY
8.6. US MARKET OVERVIEW
8.6.1. US Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
8.6.2. US Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
8.7. CANADA MARKET OVERVIEW
8.7.1. Canada Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
8.7.2. Canada Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
8.8. MEXICO MARKET OVERVIEW
8.8.1. Mexico Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
8.8.2. Mexico Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
?
9. EUROPE NEUROPROTECTION MARKET REVENUE AND FORECASTS TO 2025 – COUNTRY ANALYSIS
9.1. EUROPE NEUROPROTECTION MARKET OVERVIEW
9.2. EUROPE NEUROPROTECTION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
9.3. EUROPE NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY PRODUCT (US$ MN)
9.4. EUROPE NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY APPLICATION (US$ MN)
9.5. EUROPE NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY COUNTRY
9.6. FRANCE MARKET OVERVIEW
9.6.1. France Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.6.2. France Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.7. GERMANY MARKET OVERVIEW
9.7.1. Germany Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.7.2. Germany Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
9.8. UK MARKET OVERVIEW
9.8.1. UK Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
9.8.2. UK Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)

10. ASIA PACIFIC NEUROPROTECTION MARKET REVENUE AND FORECASTS TO 2025 – COUNTRY ANALYSIS
10.1. ASIA PACIFIC NEUROPROTECTION MARKET OVERVIEW
10.2. ASIA PACIFIC NEUROPROTECTION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
10.3. ASIA PACIFIC NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY PRODUCT (US$ MN)
10.4. ASIA PACIFIC NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY APPLICATION (US$ MN)
10.5. ASIA PACIFIC NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY COUNTRY
?
10.6. CHINA MARKET OVERVIEW
10.6.1. China Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.6.2. China Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.7. INDIA MARKET OVERVIEW
10.7.1. India Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.7.2. India Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
10.8. JAPAN MARKET OVERVIEW
10.8.1. Japan Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
10.8.2. Japan Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)

11. MIDDLE EAST AND AFRICA (MEA) NEUROPROTECTION MARKET REVENUE AND FORECASTS TO 2025 – COUNTRY ANALYSIS
11.1. MIDDLE EAST AND AFRICA (MEA) NEUROPROTECTION MARKET OVERVIEW
11.2. MIDDLE EAST AND AFRICA (MEA) NEUROPROTECTION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
11.3. MIDDLE EAST AND AFRICA (MEA) NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY PRODUCT (US$ MN)
11.4. MIDDLE EAST AND AFRICA (MEA) NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY APPLICATION (US$ MN)
11.5. MIDDLE EAST AND AFRICA (MEA) NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY COUNTRY
11.6. SOUTH AFRICA MARKET OVERVIEW
11.6.1. South Africa Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.6.2. South Africa Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.7. SAUDI ARABIA MARKET OVERVIEW
11.7.1. Saudi Arabia Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.7.2. Saudi Arabia Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
11.8. UAE MARKET OVERVIEW
11.8.1. UAE Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
11.8.2. UAE Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)
?
12. SOUTH AND CENTRAL AMERICA NEUROPROTECTION MARKET REVENUE AND FORECASTS TO 2025 – COUNTRY ANALYSIS
12.1. SOUTH AND CENTRAL AMERICA NEUROPROTECTION MARKET OVERVIEW
12.2. SOUTH AND CENTRAL AMERICA NEUROPROTECTION MARKET REVENUE FORECASTS AND ANALYSIS (US$ MN)
12.3. SOUTH AND CENTRAL AMERICA NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY PRODUCT (US$ MN)
12.4. SOUTH AND CENTRAL AMERICA NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY APPLICATION (US$ MN)
12.5. SOUTH AND CENTRAL AMERICA NEUROPROTECTION MARKET REVENUE AND FORECASTS ANALYSIS – BY COUNTRY
12.6. BRAZIL MARKET OVERVIEW
12.6.1. Brazil Neuroprotection Market Revenue Forecasts and Analysis - By Product (US$ Mn)
12.6.2. Brazil Neuroprotection Market Revenue Forecasts and Analysis - By Application (US$ Mn)

13. NEUROPROTECTION MARKET, KEY COMPANY PROFILES
13.1. ELI LILLY AND COMPANY
13.1.1. Key Facts
13.1.2. Business Description
13.1.3. Financial Overview
13.1.4. Product Portfolio
13.1.5. SWOT Analysis
13.1.6. Key Developments
13.2. ALLERGAN PLC
13.2.1. Key Facts
13.2.2. Business Description
13.2.3. Financial Overview
13.2.4. Product Portfolio
13.2.5. SWOT Analysis
13.2.6. Key Developments
?
13.3. DR. REDDY’S LABORATORIES LTD.
13.3.1. Key Facts
13.3.2. Business Description
13.3.3. Financial Overview
13.3.4. Product Portfolio
13.3.5. SWOT Analysis
13.3.6. Key Developments
13.4. TEVA PHARMACEUTICAL INDUSTRIES LTD.
13.4.1. Key Facts
13.4.2. Business Description
13.4.3. Financial Overview
13.4.4. Product Portfolio
13.4.5. SWOT Analysis
13.4.6. Key Developments
13.5. DAIICHI SANKYO COMPANY, LIMITED
13.5.1. Key Facts
13.5.2. Business Description
13.5.3. Financial Overview
13.5.4. Product Portfolio
13.5.5. SWOT Analysis
13.5.6. Key Developments
13.6. NOVARTIS AG
13.6.1. Key Facts
13.6.2. Business Description
13.6.3. Financial Overview
13.6.4. Product Portfolio
13.6.5. SWOT Analysis
13.6.6. Key Developments
?
13.7. F. HOFFMANN-LA ROCHE AG
13.7.1. Key Facts
13.7.2. Business Description
13.7.3. Financial Overview
13.7.4. Product Portfolio
13.7.5. SWOT Analysis
13.7.6. Key Developments
13.8. ASTRAZENECA PLC
13.8.1. Key Facts
13.8.2. Business Description
13.8.3. Financial Overview
13.8.4. Product Portfolio
13.8.5. SWOT Analysis
13.8.6. Key Developments
13.9. BIOGEN, INC.
13.9.1. Key Facts
13.9.2. Business Description
13.9.3. Financial Overview
13.9.4. Product Portfolio
13.9.5. SWOT Analysis
13.9.6. Key Developments
13.10. ASTROCYTE PHARMACEUTICALS, INC.
13.10.1. Key Facts
13.10.2. Business Description
13.10.3. Financial Overview
13.10.4. Product Portfolio
13.10.5. SWOT Analysis
13.10.6. Key Developments
?
14. APPENDIX
14.1. ABOUT THE INSIGHT PARTNERS
14.2. GLOSSARY OF TERMS
14.3. RESEARCH METHODOLOGY
The List of Companies

1. Eli Lilly and Company
2. Allergan plc
3. Dr. Reddy’s Laboratories Ltd.
4. Teva Pharmaceutical Industries Ltd.
5. Daiichi Sankyo Company
6. Novartis AG
7. F. Hoffmann-La Roche AG
8. AstraZeneca plc
9. Biogen Inc.
10. Astrocyte Pharmaceuticals, Inc.

Select License Type
USD $4550
USD $6550
USD $8550

Free

20%

customization on Pre-Booking
Pre Book